Stock Comparison
REGN vs VRTX
Regeneron Pharmaceuticals Inc and Vertex Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$80.55B
$123.94B
P/E (TTM)
19.4
28.5
Forward P/E
17.1
25.7
Price/Sales
5.2
9.9
Price/Book
2.5
6.1
EV/EBITDA
13.1
23.2
Dividend Yield
0.45%
—
Profitability
Net Margin
29.65%
35.40%
Operating Margin
24.32%
38.97%
Return on Equity
14.00%
23.50%
Return on Assets
6.53%
11.90%
Growth (YoY)
Revenue Growth
16.70%
12.50%
Earnings Growth
-4.50%
8.00%
Price & Risk
Beta
0.2
0.3
52-Week High
$810.12
$529.65
52-Week Low
$553.38
$376.62
Analyst Target
$833.54
$559.28
Compare REGN and VRTX your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.